AUTOMATING BIOMARKER VALIDATION WEBINAR

Automating Biomarker Validation Webinar

Thursday November 19th, 2009
sign up now

InforSense is accelerating Biomarker Discovery at leading biotechnology and research organisations such as Celera, Dana-Farber Cancer Institute and Children’s Hospital of Philadelphia to improve the speed and accuracy of biomarker identification and validation. InforSense solutions enable scientists to systematically analyze, compare and confirm that a set of biological findings is a putative biomarker without being dependent on informatics support.

“Fundamental contributions were made to disease understanding through InforSense solutions prioritizing literature queries and informing functional studies. Without these informatics tools, follow up studies of gene variants would be delayed.”

John Sninsky, Vice President Research, Celera

---

Register for Webinar: